alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
II

Calendar No. 80

104TH CONGRESS

1ST SESSION S. 278

[Report No. 104–58]

To authorize a certificate of documentation for the vessel SERENITY.

IN THE SENATE OF THE UNITED STATES

JANUARY 26 (legislative day, JANUARY 10), 1995

Mr. HOLLINGS introduced the following bill; which was read twice and

referred to the Committee on Commerce, Science, and Transportation

APRIL 18, 1995

Reported, under authority of the order of the Senate of April 6 (legislative

day, April 5), 1995, by Mr. PRESSLER, without amendment

A BILL

To authorize a certificate of documentation for the vessel

SERENITY.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That notwithstanding section 12106, 12107, and 12108

4 of title 46, United States Code, and section 27 of the Mer5 chant Marine Act, 1920 (46 App. U.S.C. 883), as applica6 ble on the date of enactment of this Act, the Secretary
2

S 278 RS

1 of Transportation may issue a certificate of documentation

2 for the vessel SERENITY, United States official number

3 1021393.

Calendar No. 80

104TH CONGRESS

1ST SESSION S. 278

[Report No. 104–58]

A BILL

To authorize a certificate of documentation for the

vessel SERENITY.

APRIL 18, 1995

Reported without amendment
EXHIBIT
32.1






CERTIFICATION
PURSUANT TO RULE 13a-14(b) OR


RULE
15d-14(b) and 18 U.S.C. §1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002






In
connection with the quarterly report of New Green Technologies, Inc. (the
"Company") on Form 10-Q for the period ended September 30, 2008 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Craig Huffman, Acting Chief Executive Officer and Acting Principal Financial
Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:




(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.






Date:
      November 18, 2008
            By:
            /s/  
      Craig HuffmanCraig
      HuffmanChief
      Executive Officer and Acting Principal Financial Officer
#### David Lee SMITH, Plaintiff-Appellant, v. State of NORTH CAROLINA, Defendant-Appellee.

No. 02-7770.

United States Court of Appeals, Fourth Circuit.

Submitted Jan. 16, 2003.

Decided Jan. 27, 2003.

David Lee Smith, Appellant Pro Se.

Before WILLIAMS, KING, and GREGORY, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

*170PER CURIAM.

David Lee Smith appeals the district court’s order accepting the recommendation of the magistrate judge and denying relief on his 42 U.S.C. § 1983 (2000) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm on the reasoning of the district court. *See Smith v. North Carolina,*No. CA-02-761-1 (M.D.N.C. filed Nov. 6, 2002; entered Nov. 7, 2002). We deny Smith’s motion to relieve the state court judge from his judicial obligations. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
Exhibit
      32.2





CERTIFICATION
      OF CHIEF FINANCIAL


LEV
      PHARMACEUTICALS, INC.


FORM
      10-QSB FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2005


PURSUANT
      TO 18 U.S.C. SECTION 1350, AS ADOPTED


PURSUANT
      TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





I
      am the
      Chief Financial Officer of Lev Pharmaceuticals, Inc., a Delaware corporation
      (the "Company"). I am delivering this certificate in connection with the Form
      10-QSB of the Company for the three months ended September 30, 2005 and filed
      with the Securities and Exchange Commission ("Form 10-QSB").





Pursuant
      to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge,
      the Form 10-QSB fully complies with the requirements of Section 13(a) or Section
      15(d) of the Securities Exchange Act of 1934 and that the information contained
      in the Form 10-QSB fairly presents, in all material respects, the financial
      condition and results of operations of the Company.




Date: November
              14, 2005
            By:
            /s/ Douglas
              J. BeckDouglas
                J. Beck
              Chief
                Financial Officer
Exhibit 99.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of EP MedSystems, Inc. (the "Company")
on Form 10-KSB for the year ended December 31, 2002 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Matthew C. Hill,
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350,
as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge:

     (1) The Report fully complies with the requirements of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
         material respects, the financial condition and result of operations of
         the Company.


/s/ Matthew C. Hill
-------------------
Matthew C. Hill
Chief Financial Officer
March 31, 2003
#### Mort MULLINS et al., Appellants, v. Harry S. BLANTON et al., Appellees.

Court of Appeals of Kentucky.

Oct. 2, 1964.

Rehearing Denied Feb. 5, 1965.

Paul C. Combs, Combs & Combs, Pres-tonsburg, for appellants.

George Chad Perry, III, Paintsville, for appellees.

CLAY, Commissioner.

In this workmen’s compensation case the employee was awarded total and permanent disability benefits. The award was confirmed by the circuit court. Questions raised on this appeal are encompassed in the contention that there was not “substantial evidence of sufficient probative value” to support the award.

The employee claims to have been injured when lifting heavy material on March 2, 1961. Though he worked a few days thereafter, he complained of pain in his back and leg. He was examined by several doctors, including one appointed by the Board. Two of them found symptoms indicating a herniated disc. X-rays failed to disclose this, but all the doctors observed subjective symptoms of limitation of motion and disabling pain.

There is evidence the employee exaggerated his symptoms. It is appellants’ contention that he was malingering and there was no substantial evidence to support the finding of a serious injury or total and permanent disability. Though there was a difference of opinion among the physicians who examined him, there was positive medical evidence, even if based on subjective symptoms, that the employee suffered an injury to his back which resulted in such disability. It is the Board’s duty to weigh and evaluate the evidence. There was sufficient evidence of substance to support the award.

The judgment is affirmed.
EXHIBIT
32.1






CERTIFICATION
PURSUANT TO RULE 13a-14(b) OR




RULE
15d-14(b) and 18 U.S.C. §1350,




AS
ADOPTED PURSUANT TO




SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002






In
connection with the quarterly report of New Green Technologies, Inc. (the
"Company") on Form 10-Q for the period ended June 30, 2008 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Craig
Huffman, Acting Chief Executive Officer and Acting Principal Financial Officer
of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:




(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and




(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.






Date:
      August 11, 2008
            By:
            /s/  
      Craig HuffmanCraig
      HuffmanChief
      Executive Officer andActing
      Principal Financial Officer
EXHIBIT 32.1

Certification of
American River Bankshares
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
regarding Quarterly Report on Form 10-Q for the quarter ended September 30,
2009

Pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code), each of the
undersigned officers of American River Bankshares, a California corporation
(the Company), does hereby certify that:

| |    |                                                                                                                                                                                                                                 
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| | 1. | The
 Companys Quarterly Report on Form 10-Q for the quarter ended September 30,
 2009 (the Form 10-Q) fully complies with the requirements of Section 13(a)
 or 15(d) of the Securities Exchange Act of 1934, as amended; and
| |    |                                                                                                                                                                                                                                 
| | 2. | Information
 contained in the Form 10-Q fairly presents, in all material respects, the
 financial condition and results of operations of the Company.                                                                           

| |                          |  |                                       
| | ------------------------ |  | --------------------------------------
| | Dated:
 November 5, 2009 |  | By: /s/
 DAVID T. TABER               
| |                          |  |                                       
| |                          |  | David T.
 Taber                       
| |                          |  | President
 and Chief Executive Officer
| |                          |  |                                       
| | Dated:
 November 5, 2009 |  | By: /s/
 MITCHELL A. DERENZO          
| |                          |  |                                       
| |                          |  | Mitchell A.
 Derenzo                  
| |                          |  | Executive
 Vice President and         
| |                          |  | Chief
 Financial Officer              

A
signed original of this written statement required by Section 906 has been
provided to American River Bankshares and will be retained by American River
Bankshares and furnished to the Securities and Exchange Commission or its staff
upon request.

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF THE COMPANY INCLUDED ELSEWHERE HEREIN WHICH HAVE BEEN
AUDITED BY COOPERS & LYBRAND L.L.P. INDEPENDENT ACCOUNTANTS AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH ANNUAL REPORT ON FORM 10-KSB.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                       6,274,967
<SECURITIES>                                         0
<RECEIVABLES>                                  427,790
<ALLOWANCES>                                         0
<INVENTORY>                                    402,381
<CURRENT-ASSETS>                             7,302,849
<PP&E>                                         449,967
<DEPRECIATION>                                 126,139
<TOTAL-ASSETS>                               8,014,574
<CURRENT-LIABILITIES>                          890,535
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       142,591
<OTHER-SE>                                   6,747,368
<TOTAL-LIABILITY-AND-EQUITY>                 8,014,574
<SALES>                                              0
<TOTAL-REVENUES>                             1,093,341
<CGS>                                                0
<TOTAL-COSTS>                                1,081,197
<OTHER-EXPENSES>                             5,373,373
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             122,693
<INCOME-PRETAX>                            (5,238,536)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (5,238,536)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (5,238,536)
<EPS-PRIMARY>                                   (0.47)
<EPS-DILUTED>                                        0


</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         800,255
<SECURITIES>                                         0
<RECEIVABLES>                                7,999,122
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                     587,752,308
<DEPRECIATION>                              18,162,480
<TOTAL-ASSETS>                             585,088,049
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       211,823
<OTHER-SE>                                 443,037,724
<TOTAL-LIABILITY-AND-EQUITY>               585,088,049
<SALES>                                              0
<TOTAL-REVENUES>                            61,911,757
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                            26,143,740
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           9,048,898
<INCOME-PRETAX>                             23,484,930
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         23,484,930
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                23,484,930
<EPS-PRIMARY>                                     1.60
<EPS-DILUTED>                                     1.58


</TABLE>
Exhibit
      32.1





**CERTIFICATION
      OF CHIEF EXECUTIVE OFFICER**


**LEV
      PHARMACEUTICALS, INC.**


**PURSUANT
      TO 18 U.S.C. SECTION 1350, AS ADOPTED**


**PURSUANT
      TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Quarterly Report of Lev Pharmaceuticals, Inc. (the
“Company”) on Form 10-QSB for the period ending March 31, 2007 as filed with the
      Securities and Exchange Commission on the date hereof (the “Report”), I, Joshua
      D. Schein, Ph.D., Chief Executive Officer of the Company, certify, pursuant
      to
      18 U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act,
      that:





(1)
          The report fully complies with the requirements of Section
      13(a) or 15(d) of the Securities Exchange Act of 1934; and




(2)
          The information contained in the Report fairly presents, in
      all material respects, the financial condition and result of operations of
      the
      Company.




Date: May
              15,
              2007
            
            /s/ Joshua
              D.
              Schein, Ph.D.Joshua
                D. Schein, Ph.D.
              Chief
                  Executive Officer




*This
      Certification is being furnished solely to accompany the Report pursuant to
      18
      U.S.C. Section 1350, as adopted pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, and shall not be deemed “filed” by the Company for
      purposes of Section 18 of the Securities Act of 1933, as amended, or the
      Securities Exchange Act of 1934, as amended, whether made before or after the
      date of this Report, irrespective of any general incorporation language
      contained in such filing. A signed original of this written statement required
      by Section 906 has been provided to Lev Pharmaceuticals, Inc. and will be
      retained by Lev Pharmaceuticals, Inc. and furnished to the Securities and
      Exchange Commission or its staff upon request* *.*
1 No. 01 -15- 00 399- CR

In the

Court of Appeals

For the

First District of Texas

At Houston

_________________________________________________________

Trial Court Cause No. 1391752

In the 339 th District Court

of Harris County, Texas

_________________________________________________________



### DENE RAY McCARTER

,

Appellant

v.



### THE STATE OF TEXAS

,

Appellee

___________________________________________________________

2 ND MOTION FOR EXTENSION OF TIME TO FILE APPELLANT’S BRIEF

__________________________________________________________

VIVIAN R. KING

State Bar No. 00784399

2202 Alabama St.

Houston, Texas 77004

(713) 222-2019 Office

(877) 753-6706 eFax

Appointed Attorney for Appellant ACCEPTED

01-15-00399-CR

FIRST COURT OF APPEALS

HOUSTON, TEXAS

11/2/2015 10:52:13 AM

CHRISTOPHER PRINE

CLERK2

TO THE HONORABLE COURT OF APPEALS:

NOW COMES DENE RAY McCARTER , the Appellant herein, and moves

the Court for an extension of time to file Appellant's Brief in this cause, pursuant to

TEX. R. APP. PROC. Rules 10.5 (b)(2) and 38.6(n) , and in support thereof

would show the Court as follows:

I.

The Appellant in this cause was convicted by a jury of Murder in the 33 9 th

District Court of Harris County, Texas in cause number 1 3 91752 and App ellant

was sentenced to 52 years in Prison in the Texas Department of Corrections,

Institutional Division. Notice of Appeal was properly filed on December 04, 2014

.

II.

The Clerk’s record was properly filed on June 15, 2015

.

The Reporter’s record was filed on July 09, 2015

.

The Exhibits were filed on July 15, 2015.

This is a voluminous record. The case is complicated.

III.

One previous extension ha s been granted.

Appellant’s attorney is requesting a n extension to November 06, 2015 to file

Appellant’s Brief

.3 IV.

Appellant’s attorney is requesting this extension of time to file Appellant’s

Brief due to weekly trial settings and other cases requiring research and court

appearances, and, specifically a 25 to Life case set on Monday, Novem ber 02, 2015

in the 179 th District Court (Casue #1450399).

This motion is not made for delay, but instead, to ensure effective assistance

of counsel.

WHEREFORE, PREMISES CONSIDERED, the undersigned counsel, on

behalf of Appellant, respectfully prays th at this Honorable Court grant this

extension to November 06 , 2015

.

RESPECTFULLY SUBMITTED,

/s/ Vivian R. King

VIVIAN R. KING

Texas Bar No. 00784399

2202 Alabama St.

Houston, Texas 77004

(713) 222

- 2019 office

(877) 753

- 6706 e Fax

VivianRKing@msn.com Email

CERTIFICATE OF SERVICE

As Attorney of Record for Appellant, I do hereby certify that a true and correct

copy of the above and foregoing document was emailed to Appellate Division and

efiled with the office of the Honorable Devon Anderson, Harris County District

Attorney, o n November 02 , 2015.

/s/ Vivian R. King
Exhibit 32.1
 Certification of the Chief Executive Officer
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
 (2)
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
  /s/ William D. GreenWilliam D. GreenChief Executive Officer of Accenture Ltd,
general partner of Accenture SCA
(principal executive officer) A signed original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears in typed form
within the electronic version of this written statement required by Section 906, has been provided
to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.